CoChat

Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT2A Receptors

Open access
Vazquez-Borsetti, P., Cortes, R., Artigas, F. · 2009 · Cerebral Cortex
Cited by 103

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

The prefrontal cortex (PFC) is involved in higher brain functions altered in schizophrenia. Classical antipsychotics modulate cortico-limbic circuits mainly through subcortical D2 receptor blockade, whereas second generation (atypical) antipsychotics preferentially target cortical 5-HT receptors. Anatomical and functional evidence supports a PFC-based control of the brainstem monoaminergic nuclei. Using a combination of retrograde tracing experiments and in situ hybridization we report that a substantial proportion of PFC pyramidal neurons projecting to the dorsal raphe (DR) and/or ventral tegmental area (VTA) express 5-HT(2A) receptors. Cholera-toxin B application into the DR and the VTA retrogradely labeled projection neurons in the medial PFC (mPFC) and in orbitofrontal cortex (OFC). In situ hybridization of 5-HT(2A) receptor mRNA in the same tissue sections labeled a large neuronal population in mPFC and OFC. The percentage of DR-projecting neurons expressing 5-HT(2A) receptor mRNA was approximately 60% in mPFC and approximately 75% in OFC (n = 3). Equivalent values for VTA-projecting neurons were approximately 55% in both mPFC and ventral OFC. Thus, 5-HT(2A) receptor activation/blockade in PFC may have downstream effects on dopaminergic and serotonergic systems via direct descending pathways. Atypical antipsychotics may distally modulate monoaminergic cells through PFC 5-HT(2A) receptor blockade, presumably decreasing the activity of neurons receiving direct cortical inputs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cercor/bhn204

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 59

  1. Aghajanian, 1997, Neuropharmacology, 36, 589, 10.1016/S0028-3908(97)00051-8 · DOI · Paper page
  2. Aghajanian, 1999, Brain research, 825, 161, 10.1016/S0006-8993(99)01224-X · DOI · Paper page
  3. Aghajanian, 1977, Brain research, 122, 229, 10.1016/0006-8993(77)90291-8 · DOI · Paper page
  4. Andreasen, 1997, Lancet, 349, 1730, 10.1016/S0140-6736(96)08258-X · DOI · Paper page
  5. Araneda, 1991, Neuroscience, 40, 399, 10.1016/0306-4522(91)90128-B · DOI · Paper page
  6. Arnt, 1998, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 18, 63, 10.1016/S0893-133X(97)00112-7 · DOI · Paper page
  7. Barroso-Chinea, 2008, Journal of chemical neuroanatomy, 35, 101, 10.1016/j.jchemneu.2007.08.001 · DOI
  8. Bortolozzi, 2005, Journal of neurochemistry, 95, 1597, 10.1111/j.1471-4159.2005.03485.x · DOI · Paper page
  9. 1996, 124, 87, 10.1007/BF02245608 · DOI
  10. Carlsson, 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1, 179, 10.1016/0893-133X(88)90012-7 · DOI · Paper page
  11. Carr, 2000, Journal of Neuroscience, 20, 3864, 10.1523/JNEUROSCI.20-10-03864.2000 · DOI · Paper page
  12. Catafau, 1994, Journal of Nuclear Medicine, 35, 935
  13. Celada, 2008, Biological psychiatry, 64, 392, 10.1016/j.biopsych.2008.03.013 · DOI
  14. Chen, 1995, Brain research, 674, 107, 10.1016/0006-8993(95)00020-Q · DOI
  15. Chou, 2003, Psychopharmacologia, 166, 234, 10.1007/s00213-002-1256-2 · DOI
  16. 1999, 22, 615
  17. Elvev g, 2000, Critical reviews in neurobiology, 14, 1
  18. Gobert, 1999, Neuropharmacology, 38, 315, 10.1016/S0028-3908(98)00188-9 · DOI · Paper page
  19. 2007, 53, 439
  20. Haj s, 1998, Neuroscience, 87, 95, 10.1016/S0306-4522(98)00157-2 · DOI · Paper page
  21. Hur, 2005, The Journal of comparative neurology, 483, 351, 10.1002/cne.20444 · DOI · Paper page
  22. Ichikawa, 2001, Brain research, 907, 151, 10.1016/S0006-8993(01)02596-3 · DOI
  23. Jacobs, 1992, Physiological Reviews, 72, 165, 10.1152/physrev.1992.72.1.165 · DOI · Paper page
  24. Kapur, 1999, American Journal of Psychiatry, 156, 286, 10.1176/ajp.156.2.286 · DOI · Paper page
  25. Kuroki, 2003, Brain research, 972, 216, 10.1016/S0006-8993(03)02516-2 · DOI
  26. Lambe, 2007, Neuroscience, 145, 900, 10.1016/j.neuroscience.2006.12.048 · DOI
  27. 2008, 57, 760
  28. 2000, 28, 325
  29. Martin-Ruiz, 2001, Journal of Neuroscience, 21, 9856, 10.1523/JNEUROSCI.21-24-09856.2001 · DOI · Paper page
  30. Meltzer, 1999, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 21, 106S, 10.1016/S0893-133X(99)00046-9 · DOI · Paper page
  31. Minabe, 2001, Synapse (New York, N.Y.), 40, 102, 10.1002/syn.1031 · DOI
  32. Nocjar, 2002, Neuroscience, 111, 163, 10.1016/S0306-4522(01)00593-0 · DOI · Paper page
  33. Nordstrom, 1998, Archives of General Psychiatry, 55, 283, 10.1001/archpsyc.55.3.283 · DOI
  34. Nyberg, 1999, American Journal of Psychiatry, 156, 869, 10.1176/ajp.156.6.869 · DOI · Paper page
  35. 1998, International clinical psychopharmacology, 13, S15
  36. Pazos, 1985, Brain research, 346, 231, 10.1016/0006-8993(85)90857-1 · DOI · Paper page
  37. Pehek, 2001, Brain research, 888, 51, 10.1016/S0006-8993(00)03004-3 · DOI
  38. Perez-Manso, 2006, Brain research, 1072, 91, 10.1016/j.brainres.2005.12.018 · doi:10.1016/j.brainres.2005.12.018
  39. Peyron, 1998, Neuroscience, 82, 443, 10.1016/S0306-4522(97)00268-6 · DOI · Paper page
  40. Pompeiano, 1992, Journal of Neuroscience, 12, 440, 10.1523/JNEUROSCI.12-02-00440.1992 · DOI · Paper page
  41. Pompeiano, 1994, Brain research. Molecular brain research, 23, 163, 10.1016/0169-328X(94)90223-2 · DOI · Paper page
  42. Porras, 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 26, 311, 10.1016/S0893-133X(01)00333-5 · DOI · Paper page
  43. Potkin, 2002, American Journal of Psychiatry, 159, 227, 10.1176/appi.ajp.159.2.227 · DOI · Paper page
  44. 1988, The EMBO Journal, 20, 4135
  45. 2005, Cerebral Cortex, 15, 1, 10.1093/cercor/bhh104 · DOI · Paper page
  46. Puig, 2003, Cerebral Cortex, 13, 870, 10.1093/cercor/13.8.870 · DOI · Paper page
  47. Robbins, 2000, Experimental brain research. Experimentelle Hirnforschung. Exp rimentation c r brale, 133, 130, 10.1007/s002210000407 · DOI · Paper page
  48. Tanaka, 1993, Journal of Neurophysiology, 69, 1749, 10.1152/jn.1993.69.5.1749 · DOI · Paper page
  49. Thierry, 1983, Progress in brain research, 58, 257, 10.1016/S0079-6123(08)60027-8 · DOI
  50. 1979, Neuroscience letters, 15, 103, 10.1016/0304-3940(79)96097-X · DOI
  51. Tomiyama, 1997, Brain research. Molecular brain research, 46, 281, 10.1016/S0169-328X(97)00022-3 · DOI
  52. Tong, 1996, Synapse (New York, N.Y.), 22, 195, 10.1002/(SICI)1098-2396(199603)22:3<195::AID-SYN1>3.0.CO;2-7 · DOI · Paper page
  53. Tong, 1998, Experimental brain research. Experimentelle Hirnforschung. Exp rimentation c r brale, 118, 466, 10.1007/s002210050303 · DOI
  54. Tzschentke, 2000, Critical reviews in neurobiology, 14, 131, 10.1615/CritRevNeurobiol.v14.i2.20 · DOI · Paper page
  55. Villalobos, 2005, The European journal of neuroscience, 22, 1120, 10.1111/j.1460-9568.2005.04307.x · DOI · Paper page
  56. Weinberger, 1994, Journal of Neuropsychiatry and Clinical Neurosciences, 6, 419, 10.1176/jnp.6.4.419 · DOI · Paper page
  57. Weinberger, 2001, Biological psychiatry, 50, 825, 10.1016/S0006-3223(01)01252-5 · DOI · Paper page
  58. Yokota, 2007, Neuroscience research, 59, 341, 10.1016/j.neures.2007.08.004 · DOI
  59. Zhou, 1999, Journal of Neurophysiology, 82, 2989, 10.1152/jn.1999.82.6.2989 · DOI · Paper page

Cited by

See all 103

Metadata

Authors
Vazquez-Borsetti, P., Cortes, R., & Artigas, F.
Venue
Cerebral Cortex
Published
2008-11-21
Volume
19
Issue
7
Pages
1678-1686
ISSN
  • 1047-3211 (ISSN-L)
  • 1460-2199
OpenAlex
W2131937487
Cited by
103
References
20
FWCI
2.07
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.